The difference in median number of ventilator-free days between the tocilizumab and placebo groups did not reach statistical significance (22 days for tocilizumab group vs. 16.5 days for placebo group; difference of 5.5 days; 95% CI: −2.8 to 13.0 days; P = .32).
2
0.3200
0.3200
The sentences
• The subgroup that demonstrated the largest estimated effect between high-titer and low-titer CP—patients aged <80 years who were not intubated and who were transfused within 3 days of COVID-19 diagnosis—was selected post hoc by combining several subset rules, which favored subgroups that showed a trend toward benefit of high-titer plasma.